We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Updated: 2/8/2017
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus
Updated: 2/9/2017
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus, Question 3
Status: Enrolling
Updated: 2/9/2017
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus
Updated: 2/9/2017
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus, Question 3
Status: Enrolling
Updated: 2/9/2017
Click here to add this to my saved trials
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Updated: 2/9/2017
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Status: Enrolling
Updated: 2/9/2017
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Updated: 2/9/2017
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Status: Enrolling
Updated: 2/9/2017
Click here to add this to my saved trials
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Updated: 2/9/2017
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Status: Enrolling
Updated: 2/9/2017
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Updated: 2/9/2017
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Status: Enrolling
Updated: 2/9/2017
Click here to add this to my saved trials
Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
Updated: 2/9/2017
Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
Status: Enrolling
Updated: 2/9/2017
Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
Updated: 2/9/2017
Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
Status: Enrolling
Updated: 2/9/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Updated: 2/14/2017
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Updated: 2/16/2017
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Updated: 2/16/2017
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
Click here to add this to my saved trials
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Updated: 2/16/2017
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Updated: 2/16/2017
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
Click here to add this to my saved trials
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Updated: 2/16/2017
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Updated: 2/16/2017
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
Click here to add this to my saved trials
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Updated: 2/16/2017
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Updated: 2/16/2017
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
Click here to add this to my saved trials
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Updated: 2/16/2017
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Updated: 2/16/2017
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
Click here to add this to my saved trials